Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Safety and Potential Benefit of Methylphenidate as a Symptomatic Treatment for Apathy in Veterans With Parkinson's Disease.

NCT05669170 is registered in ClinicalTrials.gov with Ralph H. Johnson VA Medical Center as lead sponsor.

NCT NCT05669170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05669170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Safety and Potential Benefit of Methylphenidate as a Symptomatic Treatment for Apathy in Veterans With Parkinson's Disease.
Lead sponsor
Ralph H. Johnson VA Medical Center
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 31, 2024
Completion date
June 30, 2028
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

apathy, parkinson disease